BRPI0508073A - método e aparelho para isolar substancialmente circulação cardìaca da circulação sistêmica aparelho para perfundir o coração com um agente terapêutico, cateter de obstrução para obstruir fluxo entre um vaso principal e um ou mais vasos ramificados, método para administrar um agente terapêutico ao coração e estrutura de suporte percutaneamente administrável para manter patência do sinus coronário - Google Patents

método e aparelho para isolar substancialmente circulação cardìaca da circulação sistêmica aparelho para perfundir o coração com um agente terapêutico, cateter de obstrução para obstruir fluxo entre um vaso principal e um ou mais vasos ramificados, método para administrar um agente terapêutico ao coração e estrutura de suporte percutaneamente administrável para manter patência do sinus coronário

Info

Publication number
BRPI0508073A
BRPI0508073A BRPI0508073-8A BRPI0508073A BRPI0508073A BR PI0508073 A BRPI0508073 A BR PI0508073A BR PI0508073 A BRPI0508073 A BR PI0508073A BR PI0508073 A BRPI0508073 A BR PI0508073A
Authority
BR
Brazil
Prior art keywords
heart
therapeutic agent
circulation
coronary sinus
support structure
Prior art date
Application number
BRPI0508073-8A
Other languages
English (en)
Inventor
David Martin Kaye
Clifton A Alferness
John Melmouth Power
Adam Lucas Bilney
Original Assignee
Kardia Pty Ltd V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kardia Pty Ltd V filed Critical Kardia Pty Ltd V
Publication of BRPI0508073A publication Critical patent/BRPI0508073A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3613Reperfusion, e.g. of the coronary vessels, e.g. retroperfusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3653Interfaces between patient blood circulation and extra-corporal blood circuit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3653Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3659Cannulae pertaining to extracorporeal circulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082Catheter tip comprising a tool
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1011Multiple balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1047Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1052Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1059Balloon catheters with special features or adapted for special applications having different inflatable sections mainly depending on the response to the inflation pressure, e.g. due to different material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1095Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation while the balloon is in an inflated state or in a deflated state, e.g. permanent by-pass within catheter shaft
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/12Blood circulatory system
    • A61M2210/127Aorta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/025Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)

Abstract

"MéTODO E APARELHO PARA ISOLAR SUBSTANCIALMENTE CIRCULAçãO CARDìACA DA CIRCULAçãO SISTêMICA, APARELHO PARA PERFUNDIR O CORAçãO COM UM AGENTE TERAPêUTICO, CATETER DE OBSTRUçãO PARA OBSTRUIR FLUXO ENTRE UM VASO PRINCIPAL E UM OU MAIS VASOS RAMIFICADOS, MéTODO PARA ADMINISTRAR UM AGENTE TERAPêUTICO AO CORAçãO E ESTRUTURA DE SUPORTE PERCUTANEAMENTE ADMINISTRáVEL PARA PATêNCIA DO SINUS CORONáRIO" Em um método para isolar substancialmente a circulação cardíaca da circulação sistêmica (300), o fluxo entre o sinus coronário e o átrio direito é obstruído (202). Um dispositivo de coleta venosa tendo um lúmen de coleta e uma estrutura de suporte é localizado no sinus coronário (304). A estrutura de suporte é usada para manter patência do sinus coronário durante coleta do fuido através do lúmen de coleta (206). Um trajeto de fluxo artificial é usado para manter patência do sinus coronário durante coleta de fuido através do lúmen de coleta (206). Um trajeto de fluxo artificial é provido entre o lúmen de coleta e a uma ou mais artérias coronárias, isolando, assim, a circulação cardíaca (208). De acordo com o método, bombeamento cardíaco para circulação sistêmica pode é mantido durante isolamento da circulação cardíaca.
BRPI0508073-8A 2004-02-26 2005-02-23 método e aparelho para isolar substancialmente circulação cardìaca da circulação sistêmica aparelho para perfundir o coração com um agente terapêutico, cateter de obstrução para obstruir fluxo entre um vaso principal e um ou mais vasos ramificados, método para administrar um agente terapêutico ao coração e estrutura de suporte percutaneamente administrável para manter patência do sinus coronário BRPI0508073A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54803804P 2004-02-26 2004-02-26
US61284604P 2004-09-24 2004-09-24
PCT/AU2005/000237 WO2005082440A1 (en) 2004-02-26 2005-02-23 Isolating cardiac circulation

Publications (1)

Publication Number Publication Date
BRPI0508073A true BRPI0508073A (pt) 2007-07-17

Family

ID=34915615

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508073-8A BRPI0508073A (pt) 2004-02-26 2005-02-23 método e aparelho para isolar substancialmente circulação cardìaca da circulação sistêmica aparelho para perfundir o coração com um agente terapêutico, cateter de obstrução para obstruir fluxo entre um vaso principal e um ou mais vasos ramificados, método para administrar um agente terapêutico ao coração e estrutura de suporte percutaneamente administrável para manter patência do sinus coronário

Country Status (8)

Country Link
EP (1) EP1735037B1 (pt)
JP (1) JP4819788B2 (pt)
CN (1) CN1946449A (pt)
AU (1) AU2005216564A1 (pt)
BR (1) BRPI0508073A (pt)
CA (1) CA2557480A1 (pt)
IL (1) IL177719A0 (pt)
WO (1) WO2005082440A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7722596B2 (en) 2004-02-26 2010-05-25 Osprey Medical, Inc. Regional cardiac tissue treatment
US20070203445A1 (en) * 2004-02-26 2007-08-30 V-Kardia Pty Ltd Isolating cardiac circulation
EP1917054A4 (en) 2005-08-25 2010-12-22 Osprey Medical Inc DEVICES AND PROCEDURES FOR ORGAN PERFUSION
JP2009517343A (ja) 2005-11-14 2009-04-30 エンタープライズ パートナーズ ベンチャー キャピタル 組織損傷のための幹細胞因子療法
US8152786B2 (en) 2006-11-07 2012-04-10 Osprey Medical, Inc. Collection catheter and kit
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
US9050400B2 (en) 2008-08-12 2015-06-09 Osprey Medical, Inc. Remote sensing catheter system and methods
EP2153862A1 (en) 2008-08-14 2010-02-17 V-Kardia Pty Ltd. Reverse Catheter
WO2010129672A1 (en) 2009-05-05 2010-11-11 Miragen Therapeutics Lipophilic polynucleotide conjugates
US9295816B2 (en) 2009-12-09 2016-03-29 Osprey Medical, Inc. Catheter with distal and proximal ports
US8267887B2 (en) * 2010-05-26 2012-09-18 Miracor Medical Systems Gmbh Treating heart tissue
EP2635681B8 (en) 2010-11-05 2017-10-04 Miragen Therapeutics, Inc. Base modified oligonucleotides
AR084319A1 (es) 2010-12-15 2013-05-08 Miragen Therapeutics INHIBIDORES DE microARN (miARN O miR) QUE COMPRENDEN NUCLEOTIDOS BLOQUEADOS
AU2012252165A1 (en) 2011-05-09 2013-03-21 Cambridge Enterprise Limited Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
WO2013023126A2 (en) 2011-08-11 2013-02-14 Osprey Medical Inc. Systems and methods for limb treatment
US8177704B1 (en) * 2011-12-22 2012-05-15 Miracor Medical Systems Gmbh System and method for treating heart tissue
EP2864482A4 (en) 2012-06-21 2016-02-10 Miragen Therapeutics Inc OLIGONUCLEOTIDE INHIBITORS COMPRISING A BLOCKED NUCLEIC ACID PATTERN
CN105188715B (zh) 2013-03-15 2018-12-25 米拉根医疗股份有限公司 Mir-145的锁定核酸抑制剂及其用途
KR20150131365A (ko) 2013-03-15 2015-11-24 미라젠 세러퓨틱스 인코포레이티드 브리지드 바이사이클릭 뉴클레오시드
CN103263243B (zh) * 2013-05-17 2016-02-24 苏新军 一种阴囊内窥治疗镜
AU2014282904B2 (en) * 2013-06-20 2019-03-21 Constantinos ANAGNOSTOPOULOS Intra-aortic balloon apparatus, assist devices and methods for improving flow, counterpulsation and haemodynamics
WO2015074010A2 (en) 2013-11-18 2015-05-21 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for cardiac regeneration
WO2016022536A2 (en) 2014-08-04 2016-02-11 MiRagen Therapeutics, Inc. Inhibitors of myh7b and uses thereof
US9376681B2 (en) 2014-09-08 2016-06-28 MiRagen Therapeutics, Inc. miR-29 mimics and uses thereof
MX2017009427A (es) 2015-01-20 2017-10-02 Miragen Therapeutics Inc Inhibidores de mir-92 y usos de los mismos.
CN112791304A (zh) * 2016-07-12 2021-05-14 怡忠科技股份有限公司 体外生命支持系统
EP3586900A1 (en) * 2018-06-28 2020-01-01 Medinice S.A. Cannula for minimally invasive surgical tricuspid valve repair
NL2021401B1 (en) * 2018-07-27 2020-01-31 Stichting Katholieke Univ Heart support device with directional flow assist
CN109939287A (zh) * 2019-03-18 2019-06-28 北京大学深圳医院 一种心肌保护液灌注装置
AU2022255565A1 (en) 2021-04-08 2023-11-09 Joslin Diabetes Center, Inc. Methods of diagnosing and predicting renal decline
EP4269586A1 (en) 2022-04-29 2023-11-01 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Targeting micro rna for treatment of heart failure with preserved ejection fraction (hfpef)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA85332B (en) 1984-01-20 1985-09-25 Cedars Sinai Medical Center Method of treatment of the myocardium and catheter for retroinfusion of pharmacologic agents
DE3535641A1 (de) * 1985-10-05 1987-04-09 Manfred Wolfgang Dr Helzel Zweikompartiment-katheter
US4808163A (en) 1987-07-29 1989-02-28 Laub Glenn W Percutaneous venous cannula for cardiopulmonary bypass
US5176638A (en) * 1990-01-12 1993-01-05 Don Michael T Anthony Regional perfusion catheter with improved drug delivery control
CA2074304C (en) * 1991-08-02 1996-11-26 Cyril J. Schweich, Jr. Drug delivery catheter
US5928181A (en) * 1997-11-21 1999-07-27 Advanced International Technologies, Inc. Cardiac bypass catheter system and method of use
WO1999030765A1 (en) * 1997-12-15 1999-06-24 Cardeon Corporation Perfusion shunt apparatus and method
US6673039B1 (en) * 1997-12-19 2004-01-06 Trustees Of The University Of Pennsylvania Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal
CA2314905A1 (en) * 1997-12-19 1999-07-01 The Trustees Of The University Of Pennsylvania Transvascular delivery of a composition to an extravascular tissue of a mammal
US6508777B1 (en) * 1998-05-08 2003-01-21 Cardeon Corporation Circulatory support system and method of use for isolated segmental perfusion
US6142987A (en) * 1999-08-03 2000-11-07 Scimed Life Systems, Inc. Guided filter with support wire and methods of use
US6595963B1 (en) * 2000-09-07 2003-07-22 Coaxia, Inc. Aortic shunt for selective cerebral perfusion in stroke and cardiac arrest
US6554819B2 (en) * 2001-01-09 2003-04-29 Mount Sinai School Of Medicine Of New York University Method and device for preventing contrast associated nephropathy
DE10102045B4 (de) * 2001-01-17 2004-02-26 Bionethos Holding Gmbh Medizinische Vorrichtung zur Behandlung von Gefäßen oder sonstigen Körperröhren

Also Published As

Publication number Publication date
JP2007523701A (ja) 2007-08-23
CN1946449A (zh) 2007-04-11
JP4819788B2 (ja) 2011-11-24
CA2557480A1 (en) 2005-09-09
IL177719A0 (en) 2006-12-31
EP1735037A1 (en) 2006-12-27
EP1735037B1 (en) 2015-05-20
WO2005082440A1 (en) 2005-09-09
EP1735037A4 (en) 2008-03-12
AU2005216564A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
BRPI0508073A (pt) método e aparelho para isolar substancialmente circulação cardìaca da circulação sistêmica aparelho para perfundir o coração com um agente terapêutico, cateter de obstrução para obstruir fluxo entre um vaso principal e um ou mais vasos ramificados, método para administrar um agente terapêutico ao coração e estrutura de suporte percutaneamente administrável para manter patência do sinus coronário
WO2008027272A3 (en) Isolating cardiac circulation
Aragon et al. Percutaneous left ventricular assist device:“TandemHeart” for high‐risk coronary intervention
ATE269742T1 (de) System zur durchführung von endovaskulären eingriffen
DE69532686D1 (de) Kardioplegia-kathetersystem
Zalewski et al. Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with intermittent occlusion.
DE60134790D1 (de) Katheterschaft mit mehreren leitungen zur verminderung von gliedischämie
WO2001049236A3 (en) Method and system for treating cardiac arrest
WO2008021997A3 (en) Apparatus and methods for delivering transvenous leads
ATE444049T1 (de) Zentralvenöser katheter mit wärmeaustauschmembran
ES2169135T3 (es) Un sistema de cateter para proporcionar un soporte de bomba de bypass cardiopulmonar durante una cirugia cardiaca.
WO2012154220A2 (en) Method of resuscitation
Czerwonko et al. Cardiovascular perforation during placement of an Avalon Elite® Bicaval dual lumen ECMO cannula in a newborn
Dardas et al. ECMO as a bridge to high-risk rotablation of heavily calcified coronary arteries
Shinar et al. Emergency department initiation of cardiopulmonary bypass: a case report and review of the literature
Russo et al. Prevention of limb ischemia and edema during peripheral venoarterial extracorporeal membrane oxygenation in adults
Sarkar et al. Percutaneous left ventricular support devices
O'Connor et al. Echocardiographically guided balloon atrial septostomy during extracorporeal membrane oxygenation (ECMO)
Kalbhenn et al. Bedside repositioning of a dislocated Avalon-cannula in a running veno-venous ECMO
Tabayashi et al. Replacement of the transverse aortic arch for type A acute aortic dissection
Chang et al. Comparison of venous drainage in reverse-flow island flaps: an experimental study of the rabbit saphenous fasciocutaneous flap
Niyyar Anterior chest wall arteriovenous grafts: an underutilized form of hemodialysis access
Read et al. Improved cannulation method for extracorporeal membrane oxygenation
Hinkel et al. Selective pressure-regulated retroinfusion for gene therapy application in ischemic heart disease
Long et al. Total arch replacement using a 4‐branched vascular graft without circulatory arrest

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]